Renaissance Technologies LLC

Institutional investor · Portfolio as of Q2 2026

Top Holdings3,140 positions

Checking export access…
Activity:
NVDA

NVIDIA Corporation

7.1M$1.4B2.0%$186.91-9.64%
14 qtrssince 2023-Q1
Increased
81
META

Meta Platforms, Inc.

2M$1.1B1.6%$563.89+13.74%
2 qtrssince 2026-Q1
Increased
81
INTC

Intel Corporation

7.3M$1B1.4%$31.89+82.30%
7 qtrssince 2024-Q4
Decreased
0
UTHR

United Therapeutics Corporation

1.7M$925.8M1.3%$101.27+481.24%
28 qtrssince 2019-Q3
Decreased
0
PLTR

Palantir Technologies Inc.

7.6M$883M1.2%$25.56+560.43%
21 qtrssince 2021-Q2
Increased
54
GOOGL

Alphabet Inc.

2.3M$828.2M1.1%$335.04-14.22%
13 qtrssince 2023-Q2
Increased
81
EXEL

Exelixis, Inc.

13.4M$730.6M1.0%$20.50+244.36%
28 qtrssince 2019-Q3
Decreased
0
VRSN

VeriSign, Inc.

2.4M$616.3M0.8%$196.37+58.43%
28 qtrssince 2019-Q3
Decreased
0
KGC

Kinross Gold Corporation

24.7M$584.5M0.8%$5.68+279.32%
28 qtrssince 2019-Q3
Decreased
0
CRWD

CrowdStrike Holdings, Inc.

748,960$571.6M0.8%$190.79+18.33%
1 qtr
New
61
STRL

Sterling Infrastructure, Inc.

672,194$564.2M0.8%$48.98+491.22%
28 qtrssince 2019-Q3
Decreased
0
GOOG

Alphabet Inc.

1.6M$556.8M0.8%$341.78-16.64%
4 qtrssince 2025-Q3
Increased
71
AMZN

Amazon.com, Inc.

2.3M$546M0.8%$238.34+13.65%
1 qtr
New
61
AGX

Argan, Inc.

648,379$517.8M0.7%$117.15+159.85%
28 qtrssince 2019-Q3
Increased
47
NFLX

Netflix, Inc.

6.8M$484.7M0.7%$71.41-11.42%
9 qtrssince 2024-Q2
Increased
71
CVX

Chevron Corporation

2.9M$475.8M0.7%$153.85+37.29%
10 qtrssince 2024-Q1
Increased
59
TSLA

Tesla, Inc.

1.1M$467.3M0.6%$425.84-10.82%
4 qtrssince 2025-Q3
Increased
71
AMD

Advanced Micro Devices, Inc.

829,697$463.8M0.6%$479.35+7.48%
4 qtrssince 2025-Q3
Increased
71
AAPL

Apple Inc.

1.6M$459.1M0.6%$253.34+37.57%
2 qtrssince 2026-Q1
Decreased
0
CORT

Corcept Therapeutics Incorporated

5.3M$457.5M0.6%$16.34+348.91%
28 qtrssince 2019-Q3
Decreased
0
$72.6B
AUM
3,140
Positions
Q2 2026
Filing
HI rating · 2.0/5
Quarterly 13F Value Change
Reported 13F value ($B)
Reported 13F values and quarter-over-quarter reported value changes; not investment returns.
QuarterReported value in US dollarsReported value change
2025-Q1$66,072,250,548-2.19310652693%
2025-Q2$75,171,481,59313.77163782%
2025-Q3$75,753,182,5160.773831924917%
2025-Q4$64,461,244,358-14.9062227922%
2026-Q1$63,929,893,013-0.82429582347%
2026-Q2$72,617,871,97413.5898537469%
Activity profile
$ moved · Q2'26
New16%Increased37%Decreased34%Exited12%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 5.0 years
<1Q4%1-4Q6%1-2Y6%2Y+84%

Renaissance Technologies LLC manages $72.6B across 3140 positions as of Q2 2026. Top holdings: NVDA (2.0%), META (1.6%), INTC (1.4%). Fund DNA: Diversified Scout. HoldingsIntel Score: 2/5.0.

Q2 2026 Summary

Active quarter - 563 new positions, 636 exits, 1074 increased. Top move: NVDA (INCREASED, conviction 81). Portfolio: $72.6B across 3140 positions.

Top holdings by portfolio weight

Total AUM$73B
NVDA1.95%
META1.57%
INTC1.41%
UTHR1.27%
PLTR1.22%
GOOGL1.14%
EXEL1.01%
VRSN0.85%
KGC0.80%
CRWD0.79%
Other0.78%

Portfolio allocation by GICS sector

Sectors11
Technology23.64%
Healthcare14.81%
Consumer Cyclical11.24%
Industrials10.38%
Communication Services8.89%
Financial Services8.62%
Energy5.73%
Basic Materials5.69%
Unknown3.48%
Consumer Defensive3.25%
Other4.26%

Behavioral investing profile

Checking access…
Diversified Scout- primarily Technology, Healthcare, Consumer Cyclical
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Below Average(2.0 / 5.0)
Holdings P&L44
Conviction49
Concentration18
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
7Q
ACRVACRVAcrivon Therapeutics, Inc.
Q4 2024 → Q2 2026+712,963 shares+$1M
7Q
CHGGCHGGChegg, Inc.
Q4 2024 → Q2 2026+2M shares+$936,762
7Q
CRCTCRCTCricut, Inc.
Q4 2024 → Q2 2026+333,411 shares+$57,703
Checking access…

Famous Investors' Portfolios

What the most-followed managers hold, and what they bought and sold each quarter.

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Optional analytics helps us improve. How it’s used